DaVita Inc.
DVANYSEHealthcare● Active
$191.96
$-0.20(-0.10%)
Market Cap$12.3B
P/E Ratio—
52W High$202.69
52W Low$101
DaVita Inc. (DVA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DVA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$2.87
Est. $2.41 · +19.1%
Revenue
$3.42B
Est. $3.36B · +1.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 2-Quarter EPS Beat Streak
DVA reports quarterly as a NYSE-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $3.84 | — | — | — | $3.50B | — |
| ▲ Q2 FY2026 | May 5, 2026 | $2.41 | $2.87 | +19.1% | $3.42B | $3.36B | +1.8% |
| ▲ Q1 FY2026 | Feb 2, 2026 | $3.24 | $3.40 | +4.9% | $3.62B | $3.51B | +3.2% |
| ▼ Q4 FY2025 | Oct 29, 2025 | $3.17 | $2.51 | -20.8% | $3.42B | $3.43B | -0.2% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $2.70 | $2.95 | +9.3% | $3.38B | $3.44B | -1.8% |
| ▲ Q2 FY2025 | May 12, 2025 | $1.95 | $2.00 | +2.6% | $3.22B | $3.21B | +0.5% |
| ▲ Q1 FY2025 | Feb 13, 2025 | $2.14 | $2.24 | +4.7% | $3.29B | $3.27B | +0.9% |
| ▼ Q4 FY2024 | Oct 29, 2024 | $2.72 | $2.59 | -4.8% | $3.26B | $3.27B | -0.1% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$3.84
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$2.87
EPS Est.
$2.41
EPS Surpr.
+19.1%
Revenue
$3.42B
Q1 FY2026
Feb 2, 2026Beat
EPS Actual
$3.40
EPS Est.
$3.24
EPS Surpr.
+4.9%
Revenue
$3.62B
Q4 FY2025
Oct 29, 2025Miss
EPS Actual
$2.51
EPS Est.
$3.17
EPS Surpr.
-20.8%
Revenue
$3.42B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$2.95
EPS Est.
$2.70
EPS Surpr.
+9.3%
Revenue
$3.38B
Q2 FY2025
May 12, 2025Beat
EPS Actual
$2.00
EPS Est.
$1.95
EPS Surpr.
+2.6%
Revenue
$3.22B
Q1 FY2025
Feb 13, 2025Beat
EPS Actual
$2.24
EPS Est.
$2.14
EPS Surpr.
+4.7%
Revenue
$3.29B
Q4 FY2024
Oct 29, 2024Miss
EPS Actual
$2.59
EPS Est.
$2.72
EPS Surpr.
-4.8%
Revenue
$3.26B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $4.79 | $4.85 | $4.90 | 1 |
| Q3 FY2027 | $4.34 | $4.40 | $4.44 | 1 |
| Q2 FY2027 | $4.24 | $4.30 | $4.35 | 1 |
| Q1 FY2027 | $3.21 | $3.25 | $3.29 | 1 |
| Q4 FY2026 | $4.19 | $4.24 | $4.29 | 1 |
| Q3 FY2026 | $3.86 | $3.91 | $3.96 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $3.7B | $3.7B | $3.8B | 1 |
| Q3 FY2027 | $3.6B | $3.6B | $3.7B | 2 |
| Q2 FY2027 | $3.5B | $3.6B | $3.6B | 2 |
| Q1 FY2027 | $3.4B | $3.5B | $3.5B | 1 |
| Q4 FY2026 | $3.6B | $3.6B | $3.7B | 2 |
| Q3 FY2026 | $3.5B | $3.5B | $3.6B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +19.1% | $154.08 | $157.04 | +1.92% |
| ▲ Q1 FY2026 | Feb 2, 2026 | +4.9% | $109.34 | $111.19 | +1.69% |
| ▼ Q4 FY2025 | Oct 29, 2025 | -20.8% | $129.61 | $126.56 | -2.35% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +9.3% | $139.52 | $140.52 | +0.72% |
| ▲ Q2 FY2025 | May 12, 2025 | +2.6% | $143.76 | $144.43 | +0.47% |
| ▲ Q1 FY2025 | Feb 13, 2025 | +4.7% | $172.00 | $177.06 | +2.94% |
| ▼ Q4 FY2024 | Oct 29, 2024 | -4.8% | $157.05 | $158.31 | +0.80% |
| ▼ Q3 FY2024 | Aug 6, 2024 | -1.6% | $135.41 | $136.99 | +1.17% |
Q2 FY2026+1.92%
Report Date
May 5, 2026
EPS Beat/Miss
+19.1%
Price Before
$154.08
Price After
$157.04
Q1 FY2026+1.69%
Report Date
Feb 2, 2026
EPS Beat/Miss
+4.9%
Price Before
$109.34
Price After
$111.19
Q4 FY2025-2.35%
Report Date
Oct 29, 2025
EPS Beat/Miss
-20.8%
Price Before
$129.61
Price After
$126.56
Q3 FY2025+0.72%
Report Date
Aug 5, 2025
EPS Beat/Miss
+9.3%
Price Before
$139.52
Price After
$140.52
Q2 FY2025+0.47%
Report Date
May 12, 2025
EPS Beat/Miss
+2.6%
Price Before
$143.76
Price After
$144.43
Q1 FY2025+2.94%
Report Date
Feb 13, 2025
EPS Beat/Miss
+4.7%
Price Before
$172.00
Price After
$177.06
Q4 FY2024+0.80%
Report Date
Oct 29, 2024
EPS Beat/Miss
-4.8%
Price Before
$157.05
Price After
$158.31
Q3 FY2024+1.17%
Report Date
Aug 6, 2024
EPS Beat/Miss
-1.6%
Price Before
$135.41
Price After
$136.99
Avg Beat Reaction+1.55%
Avg Miss Reaction-0.13%
Beat Rate5 / 8 quarters
Largest Move+2.94% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DVA ends December
DaVita Inc. (DVA) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $2.87 — beating the analyst consensus of $2.41 by +19.1%. DVA has beaten EPS estimates for 2 consecutive quarters. The next DVA earnings date is expected around September 1, 2026.
Each quarter, investors track DVA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DVA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DVA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DVA earnings · 5 questionsDaVita Inc.'s next earnings report is expected around September 1, 2026. DVA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DVA historically reports after market close (AMC).
DVA earnings datewhen is DVA earningsDVA next earnings datewhen does DVA report earningsDVA earnings calendar
▸ Source: FMP · DaVita Inc. SEC filings · US GAAP · DaVita Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026